APO-PERINDOPRIL ARGININE DIN 02473089
Health Canada record
| Active ingredient(s) | PERINDOPRIL ARGININE 10 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | C09AA04 PERINDOPRIL |
| Original market date | |
| Current status date | 09-Mar-2018 |
| Source | Health Canada DPD |
Establishment licence of the holder
Apotex Inc — licence 100375, currently licensed, last inspection rating C (2026-04-21).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing PERINDOPRIL ARGININE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02473070 | APO-PERINDOPRIL ARGININE | APOTEX INC | Tablet | PERINDOPRIL ARGININE 5 MG | Approved |
| 02473062 | APO-PERINDOPRIL ARGININE | APOTEX INC | Tablet | PERINDOPRIL ARGININE 2.5 MG | Approved |
| 02468565 | APO-PERINDOPRIL/AMLODIPINE | APOTEX INC | Tablet | PERINDOPRIL ARGININE 3.5 MG; AMLODIPINE (AMLODIPINE BESYLATE) 2.5 MG | Marketed |
| 02468581 | APO-PERINDOPRIL/AMLODIPINE | APOTEX INC | Tablet | PERINDOPRIL ARGININE 14 MG; AMLODIPINE (AMLODIPINE BESYLATE) 10 MG | Marketed |
| 02468573 | APO-PERINDOPRIL/AMLODIPINE | APOTEX INC | Tablet | PERINDOPRIL ARGININE 7 MG; AMLODIPINE (AMLODIPINE BESYLATE) 5 MG | Marketed |
| 02451549 | VIACORAM | SERVIER CANADA INC | Tablet | PERINDOPRIL ARGININE 7 MG; AMLODIPINE (AMLODIPINE BESYLATE) 5 MG | Marketed |
| 02451530 | VIACORAM | SERVIER CANADA INC | Tablet | PERINDOPRIL ARGININE 3.5 MG; AMLODIPINE (AMLODIPINE BESYLATE) 2.5 MG | Marketed |
| 02451557 | VIACORAM | SERVIER CANADA INC | Tablet | PERINDOPRIL ARGININE 14 MG; AMLODIPINE (AMLODIPINE BESYLATE) 10 MG | Marketed |
| 02270552 | ARCOSYL | SERVIER CANADA INC | Tablet | PERINDOPRIL ARGININE 2.5 MG | Cancelled Pre Market |
| 02270560 | ARCOSYL | SERVIER CANADA INC | Tablet | PERINDOPRIL ARGININE 5 MG | Cancelled Pre Market |
| 02270579 | ARCOSYL | SERVIER CANADA INC | Tablet | PERINDOPRIL ARGININE 10 MG | Cancelled Pre Market |
| 02337932 | ARCOSYL | SERVIER CANADA INC | Tablet (Orally-Disintegrating) | PERINDOPRIL ARGININE 2.5 MG | Cancelled Pre Market |
| 02337940 | ARCOSYL | SERVIER CANADA INC | Tablet (Orally-Disintegrating) | PERINDOPRIL ARGININE 5 MG | Cancelled Pre Market |
| 02337959 | ARCOSYL | SERVIER CANADA INC | Tablet (Orally-Disintegrating) | PERINDOPRIL ARGININE 10 MG | Cancelled Pre Market |
| 02357321 | ARCOSYL PLUS | SERVIER CANADA INC | Tablet | PERINDOPRIL ARGININE 10 MG; INDAPAMIDE 2.5 MG | Cancelled Pre Market |
| 02318555 | ARCOSYL PLUS | SERVIER CANADA INC | Tablet | PERINDOPRIL ARGININE 5 MG; INDAPAMIDE 1.25 MG | Cancelled Pre Market |
| 02318563 | ARCOSYL PLUS LD | SERVIER CANADA INC | Tablet | PERINDOPRIL ARGININE 2.5 MG; INDAPAMIDE 0.625 MG | Cancelled Pre Market |
| 02440059 | MYLAN-PERINDOPRIL ARGININE | MYLAN PHARMACEUTICALS ULC | Tablet | PERINDOPRIL ARGININE 10 MG | Cancelled Pre Market |
| 02440040 | MYLAN-PERINDOPRIL ARGININE | MYLAN PHARMACEUTICALS ULC | Tablet | PERINDOPRIL ARGININE 5 MG | Cancelled Pre Market |
| 02440032 | MYLAN-PERINDOPRIL ARGININE | MYLAN PHARMACEUTICALS ULC | Tablet | PERINDOPRIL ARGININE 2.5 MG | Cancelled Pre Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 20598 | 2018-03-09 | New Drug Submission (NDS) |
International API supply for PERINDOPRIL ARGININE
4 active FDA Drug Master Files.
Request a quote for APO-PERINDOPRIL ARGININE